Insider Transactions Reported by 14 Insiders of Processa Pharmaceuticals, Inc.

Symbol
PCSA on Nasdaq
Location
Vero Beach, FL

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James H. Stanker Chief Financial Officer $61,609 05 Apr 2024
Robert Michael Floyd Chief Operating Officer $51,618 09 Feb 2023
Sian Bigora Chief Development Officer $48,037 01 Jan 2026
David Young Pres. Research & Development, Director $44,354 01 Jan 2026
Patrick Lin Chief Business - Strategy Off $43,021 01 Jan 2026
Wendy Guy Chief Administrative Officer $42,792 01 Jan 2026
Virgil Thompson Director $42,163 27 Jun 2023
George K. Ng Chief Executive Officer, Director $31,668 01 Oct 2025
Yorke Justin W. Director $11,248 01 Oct 2025
Russell Skibsted Chief Financial Officer $5,880 01 Oct 2025
James R. Neal Director 01 Oct 2025
Khalid Islam Director 31 Mar 2022
Geraldine Pannu Director 01 Oct 2025
Khoso Baluch Director 01 Oct 2025

Recent Insider Transactions by Companies or Individuals for Processa Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Patrick Lin PCSA Common Stock Options Exercise 12.4% 193 1,753 01 Jan 2026 Direct
Patrick Lin PCSA Common Stock Options Exercise -100% -193 0 01 Jan 2026 Direct
Wendy Guy PCSA Common Stock Options Exercise 18.2% 193 1,256 01 Jan 2026 Direct
Wendy Guy PCSA Restricted Stock Units Options Exercise -100% -193 0 01 Jan 2026 Direct
Sian Bigora PCSA Common Stock Options Exercise 18.4% 249 1,604 01 Jan 2026 Direct
Sian Bigora PCSA Restricted Stock Units Options Exercise -100% -249 0 01 Jan 2026 Direct
David Young PCSA Common Stock Options Exercise 0.56% 49 8,752 01 Jan 2026 Direct
David Young PCSA Restricted Stock Units Options Exercise -100% -49 0 01 Jan 2026 Direct
James R. Neal PCSA Stock Options (Right to Buy) Award 300,000 300,000 01 Oct 2025 Direct
James R. Neal PCSA Restricted Stock Units Award 100,000 100,000 01 Oct 2025 Direct
Khoso Baluch PCSA Stock Options (Right to Buy) Award 300,000 300,000 01 Oct 2025 Direct
Khoso Baluch PCSA Restricted Stock Units Award 100,000 100,000 01 Oct 2025 Direct
Geraldine Pannu PCSA Stock Options (Right to Buy) Award 300,000 300,000 01 Oct 2025 Direct
Geraldine Pannu PCSA Restricted Stock Units Award 100,000 100,000 01 Oct 2025 Direct
Justin W. Yorke PCSA Stock Options (Right to Buy) Award 300,000 300,000 01 Oct 2025 Direct
Justin W. Yorke PCSA Restricted Stock Units Award 100,000 100,000 01 Oct 2025 Direct
Wendy Guy PCSA Stock Options (Right to Buy) Award 150,000 150,000 01 Oct 2025 Direct
Wendy Guy PCSA Restricted Stock Units Award 50,000 50,000 01 Oct 2025 Direct
Patrick Lin PCSA Stock Options (Right to Buy) Award 204,000 204,000 01 Oct 2025 Direct
Patrick Lin PCSA Restricted Stock Units Award 68,000 68,000 01 Oct 2025 Direct
Sian Bigora PCSA Stock Options (Right to Buy) Award 288,000 288,000 01 Oct 2025 Direct
Sian Bigora PCSA Restricted Stock Units Award 96,000 96,000 01 Oct 2025 Direct
Russell Skibsted PCSA Stock Options (Right to Buy) Award 324,000 324,000 01 Oct 2025 Direct
Russell Skibsted PCSA Restricted Stock Units Award 108,000 108,000 01 Oct 2025 Direct
David Young PCSA Stock Options (Right to Buy) Award 333,000 333,000 01 Oct 2025 Direct
David Young PCSA Restricted Stock Units Award 111,000 111,000 01 Oct 2025 Direct
George K. Ng PCSA Stock Options (Right to Buy) Award 768,000 768,000 01 Oct 2025 Direct
George K. Ng PCSA Restricted Stock Units Award 256,000 256,000 01 Oct 2025 Direct
Wendy Guy PCSA Restricted Stock Units Award 13094.8% 1,366,046 1,376,478 24 Jul 2025 Direct
Patrick Lin PCSA Common Stock Tax liability -11.1% -4,814 38,727 01 Apr 2025 Direct
Patrick Lin PCSA Common Stock Options Exercise 49.8% 14,482 43,541 01 Apr 2025 Direct
Wendy Guy PCSA Common Stock Options Exercise 122.1% 14,482 26,339 01 Apr 2025 Direct
Sian Bigora PCSA Common Stock Tax liability -8.96% -3,311 33,626 01 Apr 2025 Direct
Sian Bigora PCSA Common Stock Options Exercise 68.8% 15,059 36,937 01 Apr 2025 Direct
David Young PCSA Common Stock Tax liability -2.4% -5,345 217,332 01 Apr 2025 Direct
David Young PCSA Common Stock Options Exercise 8.41% 17,272 222,677 01 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.